Company news
TheraCryf PLC news in 2019
TheraCryf PLC's news releases, calls and decks from 2019, newest first.
Investor presentation
December 17, 2019
MOU with The University of Dundee
December 5, 2019
SAS study clarification
November 11, 2019
ESMO presentation of Phase II STEM clinical data
September 30, 2019
Update on extended-use phase of STEM trial
September 23, 2019
Agreement for supply of SFX-01 for autism trial
September 5, 2019
Update on SAS study
August 28, 2019
Grant of further European patent
August 7, 2019
Research collaboration
August 5, 2019
AGM Statement
July 18, 2019
SFX-01 featured in SAH review paper
June 24, 2019
Posting of Annual Report and AGM Notice
June 19, 2019
Notification of Preliminary Results
June 11, 2019
Share Option Exercise and Issue of Equity
May 21, 2019
Result of GM and Completion of Placing
May 8, 2019
Posting of Circular and Timing of General Meeting
April 18, 2019
Placing and Notice of General Meeting
April 17, 2019
finnCap publishes initiation research
April 2, 2019
Poster presentation of Imperial College data
March 28, 2019
SFX-01 meets primary endpoints in STEM trial
March 25, 2019
Update on SFX-01 trial read-out dates
March 18, 2019
SFX-01 data published in peer reviewed journal
March 5, 2019
Clinical trial update confirms read-outs on track
February 5, 2019
SFX-01 featured in Nature Reviews Drug Discovery
January 23, 2019
Decks in 2019
- Evgen Pharma — Shareholder Meeting (July 2019)
Shareholder meeting · 16 slides · Jul 18, 2019